Inhibition of D1, D2, and a cyclin expression in HL-60 cells by the lipid peroxydation product 4-hydroxynonenal

被引:47
作者
Pizzimenti, S
Barrera, G
Dianzani, MU
Brüsselbach, S
机构
[1] Univ Turin, Dipartimento Med & Oncol Sperimentale, Sez Patol Gen, I-10125 Turin, Italy
[2] Univ Marburg, IMT, Marburg, Germany
关键词
lipid peroxidation; 4-hydroxynonenal; HL-60 cell line; proliferation; cyclins; CDKs; free radicals;
D O I
10.1016/S0891-5849(99)00022-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
4-Hydroxynonenal (HNE), a product of lipid peroxidation. is an highly reactive aldehyde that, at concentration similar to those found in normal cells, blocks proliferation and induces a granulocytic-like differentiation in HL-60 cells. These effects are accompained by a marked increase in the proportion G0/G1 cells. The mechanisms of HNE action were investigated by analyzing the expression of the cyclins and cyclin-dependent protein kinases (CDKs), controlling the cell cycle progression. Data obtained by exposing cells to dimethyl sulfoxide (DMSO) were used for comparison. 4-Hydroxynonenal downregulated both mRNA and protein contents of cyclins D1, D2, and A until 24 h from the treatments, whereas DMSO inhibited cyclin D1 and D2 expression until the end of experiment (2 days) and induces an increase of cyclin A until 1 day. Cyclins B and E, and protein kinase CDK2 and CDK4 expressions were not affected by HNE, whereas DMSO induced an increase of cyclin E, B, and CDK2 from 8 h to 1 day. These data are in agreement with previous results indicating a different time-course of accumulation in G0/G1 phases of cells treated with HNE and DMSO and suggest that the HNE inhibitory effect on proliferation and cell cycle progression may depend by the downregulation of D1, D2, and A cyclin expression. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:1578 / 1586
页数:9
相关论文
共 41 条
[1]   INCREMENT OF THE CYCLIN-D1 MESSENGER-RNA LEVEL IN TPA-TREATED 3 HUMAN MYELOID-LEUKEMIA CELL-LINES - HEL, CMK AND HL-60 CELLS [J].
AKIYAMA, N ;
SASAKI, H ;
KATOH, O ;
SATO, T ;
HIRAI, H ;
YAZAKI, Y ;
SUGIMURA, T ;
TERADA, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 195 (02) :1041-1049
[2]   CYCLIN D1 IS A NUCLEAR-PROTEIN REQUIRED FOR CELL-CYCLE PROGRESSION IN G(1) [J].
BALDIN, V ;
LUKAS, J ;
MARCOTE, MJ ;
PAGANO, M ;
DRAETTA, G .
GENES & DEVELOPMENT, 1993, 7 (05) :812-821
[3]   EFFECT OF 4-HYDROXYNONENAL ON C-MYC EXPRESSION [J].
BARRERA, G ;
MARTINOTTI, S ;
FAZIO, V ;
MANZARI, V ;
PARADISI, L ;
PAROLA, M ;
FRATI, L ;
DIANZANI, MU .
TOXICOLOGIC PATHOLOGY, 1987, 15 (02) :238-240
[4]   INDUCTION OF DIFFERENTIATION IN HUMAN HL-60 CELLS BY 4-HYDROXYNONENAL, A PRODUCT OF LIPID-PEROXIDATION [J].
BARRERA, G ;
DIMAURO, C ;
MURACA, R ;
FERRERO, D ;
CAVALLI, G ;
FAZIO, VM ;
PARADISI, L ;
DIANZANI, MU .
EXPERIMENTAL CELL RESEARCH, 1991, 197 (02) :148-152
[5]   Effect of 4-hydroxynonenal on cell cycle progression and expression of differentiation-associated antigens in HL-60 cells [J].
Barrera, G ;
Pizzimenti, S ;
Muraca, R ;
Barbiero, G ;
Bonelli, G ;
Baccino, FM ;
Fazio, VM ;
Dianzani, MU .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (03) :455-462
[6]   INHIBITION OF C-MYC EXPRESSION INDUCED BY 4-HYDROXYNONENAL, A PRODUCT OF LIPID-PEROXIDATION, IN THE HL-60 HUMAN LEUKEMIC-CELL LINE [J].
BARRERA, G ;
MURACA, R ;
PIZZIMENTI, S ;
SERRA, A ;
ROSSO, C ;
SAGLIO, G ;
FARACE, MG ;
FAZIO, VM ;
DIANZANI, MU .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 203 (01) :553-561
[7]   4-hydroxynonenal specifically inhibits c-myb but does not affect c-fos expressions in HL-60 cells [J].
Barrera, G ;
Pizzimenti, S ;
Serra, A ;
Ferretti, C ;
Fazio, VM ;
Saglio, G ;
Dianzani, MU .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 227 (02) :589-593
[8]  
BURGER C, 1994, J CELL SCI, V107, P2047
[9]   LIPID-PEROXIDATION IN REGENERATING RAT-LIVER [J].
CHEESEMAN, KH ;
COLLINS, M ;
MADDIX, S ;
MILIA, A ;
PROUDFOOT, K ;
SLATER, TF ;
BURTON, GW ;
WEBB, A ;
INGOLD, KU .
FEBS LETTERS, 1986, 209 (02) :191-196
[10]   INHIBITION OF THE MELANOMA CELL-CYCLE AND REGULATION AT THE G1/S TRANSITION BY 12-O-TETRADECANOYLPHORBOL-13-ACETATE (TPA) BY MODULATION OF CDK2 ACTIVITY [J].
COPPOCK, DL ;
BUFFOLINO, P ;
KOPMAN, C ;
NATHANSON, L .
EXPERIMENTAL CELL RESEARCH, 1995, 221 (01) :92-102